Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

NCT00456833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: RAD001
DRUG: erlotinib

Sponsor

Novartis Pharmaceuticals